No evidence of disease activity in anti-JC virus seronegative patients with early relapsing-remitting multiple sclerosis treated with natalizumab: a prespecified 2-year analysis of STRIVE
MULTIPLE SCLEROSIS JOURNAL（2017）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined